Highlights the Sigma-Tau Pharmaceuticals Inc. as a leader in metabolic research. Focus on the development, acquisition and distribution of products based on naturally-occurring substances which enhance health; Financial support for advocacy group...
Sigma-Tau Pharmaceuticals, Inc.是Sigma-Tau Group的全资子公司,坐落于美国。我们致力于罕见病药物的全球研发和商业化。 研发解决方案 商业解决方案 医学解决方案 行业领域 服务 客户 资源中心 活动 网站地图 联系我们 联系我们 官方热线:+86 21 3329 5009 业务咨询:mktg_cn@veeva.com 关注我们 关于Veeva ...
Cystinosis Treatment Granted Priority Review Status GAITHERSBURG, Md., May 17 /PRNewswire/ -- Sigma-Tau Pharmaceuticals, Inc. announced today that the U.S. Food and Drug Administration (FDA) has accepted the filing of the company's new drug application (NDA) for its cysteamine hydr...
The article reports that Enzon Pharmaceuticals Inc. will sell its specialty pharmaceutical business to the Sigma-tau Group for 300 million dollars. It states that the business includes four products with mixed annual sales reaching 120 million dollars, as well as a manufacturing facility in ...
Pharmaceuticals Gastrointestinal Drugs ASKA Pharmaceutical Co., Ltd. Abbott Laboratories [+n] Leukemia Drugs Juno Therapeutics, Inc. Genmab A/S [+n] Acute Lymphocytic/Lymphoblastic Leukemia Therapeutics Market Innovation Matrix visualizing technology portfolio of hot application areas and blank areas for S...
西班牙巴塞罗那—2013年3月27日– 制药企业Sigma-Tau Pharma AG已选择基于云技术开发的CRM解决方案,以提升以客户为中心的战略。该公司的瑞士分部现已开始通过使用Veeva CRM以及专为Apple iPad设计的iRep来建立长期稳固的客户关系。 Veeva CRM能赋予Sigma-Tau必要的灵活性,帮助企业保持稳定增长,并紧跟快速变化的瑞士...
Sigma-Tau Pharmaceuticals, Inc., located in Gaithersburg, Maryland, is the U.S. subsidiary of Sigma-Tau S.p.A of Italy, which includes worldwide operations (Sigma-Tau). Although relatively new to the U.S. (commercially staffed in 1989), Sigma-Tau has become firmly established as a ...
Sigma-Tau Pharmaceuticals Swiss Affiliate Switches to Cloud-based Veeva CRM and iRep to Support Customer-Centric Business ApproachVeeva SystemsVeeva Systems
SciClone Pharmaceuticals, Inc. and Sigma-Tau S.p.A announced that SciClone's lead product candidate thymalfasin (ZADAXIN®, thymosin alpha 1) achieved its primary endpoint in a phase 2 clinical tri ...
It also revealed the detection kit, the solid scaffold related alpha - Sigma.Antibodies, immunoglobulins_lambda__ (_), and ligations of these fragments, derivatives and variants can be used in pharmaceuticals and delta_alpha gamma_ The composition of the immunotherapy and diagnosis is based on ...